BTIG keeps price targets on Serina Therapeutics and McDonald's
BTIG maintained its $8.00 per share target on Serina Therapeutics and $295.00 on McDonald's, Dow Jones Newswires reports, citing Benzinga.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
BTIG analysts kept their price target at $8.00 per share for Serina Therapeutics and $295.00 per share for McDonald's. Dow Jones Newswires reported these rating actions on October 26, citing Benzinga data.
why it matters
Maintained price targets are routine analyst updates. For the broader market such actions usually have little effect on share prices, but they show how one brokerage values individual stocks.
tags
instruments
sources
- Serina Therapeutics Price Target Maintained With a $8.00/Share by BTIG — Dow Jones Newswires, 26 October 2026 at 10:01 UTC
- McDonald's Price Target Maintained With a $295.00/Share by BTIG — Dow Jones Newswires, 26 October 2026 at 10:29 UTC
- Tempus AI Price Target Maintained With a $80.00/Share by BTIG — Dow Jones Newswires, 26 October 2026 at 10:46 UTC
- Oruka Therapeutics Price Target Maintained With a $200.00/Share by Guggenheim — Dow Jones Newswires, 27 October 2026 at 13:47 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗